A startup founded to turn a landmark one-patient gene-editing success into a repeatable treatment has abandoned its lead program and cut staff roughly seven months after launching.
Aurora Therapeutics, co-founded by Nobel laureate Jennifer Doudna and gene-editing researcher Fyodor Urnov, scrapped its lead program and cut staff, STAT reported. A company spokesperson declined to tell STAT how many employees were laid off or whether members of the three-person leadership team would remain. The company's chief scientific officer departed earlier this year.
